Immunolocalization of p53, glutathione S-tranferase π and CD57 antigens in oral leukoplakia

Anticancer Research

Volumn 21, Issue 1 A, 2001, Pages 379-386

  Batista De Paula, A M ^a   Gomez, R S ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Leukoplakia, p53, Gst , Cd57

Indexed keywords

CD57 ANTIGEN; GLUTATHIONE TRANSFERASE; ISOENZYME; PROTEIN P53;

ARTICLE; EPITHELIUM DYSPLASIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; LEUKOPLAKIA; LYMPHOCYTE COUNT; LYMPHOID CELL; MOUTH CANCER; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ANTIGENS, CD57; EPITHELIUM; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; IMMUNOENZYME TECHNIQUES; ISOENZYMES; LEUKOPLAKIA, ORAL; LYMPHOCYTES, TUMOR-INFILTRATING; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035063815     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. International Collaborative Group on Oral White Lesions. Oral white lesions with special reference to precancerous and tobacco-related lesions: Conclusions of an international symposium held in Uppsala, Sweden, May 18-21, 1994
2. International Seminar on oral lesions related to tobacco habits
3. Studies in oral leukoplakias V clinical and histologic signs of malignancy
4. Incidence of oral cancer among 30000 villagers in India in a 7-year follow-up study of oral precancerous lesions
5. Accumulation of the p53 tumor-supressor gene product in oral leukoplakia
6. p53 protein expression in sequential biopsies of oral dysplasias and in situ carcinomas
7. An immunohistochemical analysis of p53 protein expression in pre-maligmnant and malignant tissues of the oral cavity
8. Loss of p53 gene as a biomarker of high risk oral leukoplakias Indian
9. Expression of cyclin dependent kinase inhibitor p21waf1/cip1 in premalignant and malignant oral lesions: Relationship with p53 status
10. p53 expression in oral precancer as a marker for malignant potential
11. Localization of gene for human p53 tumor antigen to band 17p13
12. The p53 tumour suppressor gene
13. Multiple pathways control cell growth and transformation: Overlapping and independent activities of p53 and p21 waf1/cip1/sdi1
14. The p53 pathway
15. High levels of p53 protein in UV irradiated human skin
16. Aberrant accumulation of p53 associates with Ki67 and mitotic counts in benign skin lesions
17. Biochemical genetics of glutathione-S-transferases in man
18. The glutatione-S-transferases: An update
19. The isoenzymes of glutathione transferase
20. Significance of gluthatione S-transferase- π as a tumor marker in patients with oral cancer
21. Immunohistochemical demonstration of epithelial S-transferase isoenzymes in normal, benign, premalignant and malignant human oral mucosa
22. Sequential expression of placental gluthatione S-transferase (GST-π) during DMBA-induced hamster buccal pouch squamous cell carcinogenesis
23. Evaluation of gluthatione S-transferase activity in human buccal epithelial dysplasias and squamous cell carcinomas
24. Gluthatione S-Transferase p-class a tumour marker in lingual preneoplastic and neoplastic lesions of rats and humans
25. Differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1)
26. Neural cell adhesion molecules and myelin-associated glycoprotein share a common carboydrate moiety recognized bu monoclonal antibodies L2 and HNK-1
27. Sub-populations of human natural killer cells defined by expression of the Leu 7 (HNK-1) and Leu-ll (NK-15) antigens
28. Human lymphocyte subpopulations identified by using three-colour imunofluorescence and flow cytometric analysis: Correlation of Leu-2, Leu-3, Leu-7, leu-8 and Leu-11
29. Subsets of CD8+, CD57+ cells in normal, healthy individuals: Correlations with HCMV carrier status, phenotypic and functinal analyses
30. The role of CD8+, CD57+ cells in human cytomegalovirus and other viral infections
31. CD57+ T lymphocytes are derived from CD57- precursors by differentiation occurring in late immune responses
32. Germinal centre CD4+ T cells are an important site of HIV replication in vivo
33. high+ CD28+ CD57- cells with ageing
34. high +CD28+CD57- cells with ageing
35. Human germinal center CD4+CD57+ T cells act differently on B cells than do classical T-helper cells
36. CD8high (CD57+) T cells in normal, healthy individuals specifically suppress the generation of cytotoxic T lymphocytes to Epstein-Barr virus-transformed B cell lines
37. Increase of CD57+ T cells in knee joints and adjacent bone marrow of rheumatoid arthritis (RA) patients: Implications for an anti-inflammatory role
38. CDS+/CD57 cells and apoptosis suppress T-cell functions in multiple myeloma
39. CD8hi+ CD57+ T lymphocytes are enriched in antigen-specific T cells capable of down-modulating cytotoxic activity
40. Comparative immunophenotypic study of lichen sclerosus: Epidermotropic CD57+ lymphocytes are numerous - Implications for pathogenesis
41. Association of natural killer cell activity with serum IgE
42. Antigen retrieval in immunohistochemistry: Past, present and future
43. Leukoplakia, lichen planus and other oral keratoses in 23, 616 white americans over the age of 35 years
44. Lack of molecular markers to predict malignant potential of oral cancer
45. Observer variability in the histologic assessment of oral premalignant lesions
46. Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia
47. Histological and immunohistochemical studies of oral leukoplakia. Phenotype and distribution studies of immuno-competent cells
48. The presence of p53 protein in relation to Ki-67 as cellular proliferation marker in head and neck squamous cell carcinoma and adjacent dysplastic mucosa
49. A proposal for a classification and staging system for oral leukoplakia: A preliminary study
50. Malignant transformation of oral leukoplakia: A follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands